Hosted on MSN13h
Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer
Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...
News Medical on MSN5h
Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation
News-Medical speaks with Jordi Labs’ about its recent achievements, alignment with FDA expectations, and strategic ...
19 million Americans expected to cruise in 2025, and Florida has the 3 busiest cruise ports
"AAA forecasts 19 million Americans will go on ocean cruises in 2025," the company said in a release Sunday. "This is a 4.5% increase over 2024 when 18.2 million Americans went on cruise vacations. It ...
pharmaphorum19h
After FDA snub, EMA backs FibroGen, Astellas' roxadustat
The EU regulator has approved FibroGen and Astellas Evrenzo for adults with anaemia caused by chronic kidney disease (CKD), just days after the FDA turned down the drug in the US. The decision ...
pharmaphorum19h
FDA fast tracks type 1 diabetes cell therapy from Vertex
Vertex Pharma has made its name with treatment for cystic fibrosis, but has big plans in cell and genetic therapies – and has just chalked up fast-track status from the FDA for a cell-based ...